Invasive device-associated hospital infection rates, etiological agents, and their antibiotic susceptibilities in the medical intensive care unit of a university hospital in Turkey

Turkish Journal of Medical Sciences

Volumn 43, Issue 1, 2013, Pages 33-38

  Çevik, Saliha ^a   Boşnak, Vuslat ^a   Namiduru, Mustafa ^a   Karaoǧlan, Ilkay ^a   Mete, Ayşe Özlem ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Antibiotic susceptibilities; Intensive care unit; Invasive devices; Nosocomial infections; Surveillance

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; FLUCONAZOLE; GLYCOPEPTIDE; IMIPENEM; LINEZOLID; OXACILLIN; PIPERACILLIN; QUINOLONE; SULPERAZON; TAZOBACTAM; VANCOMYCIN;

ACINETOBACTER; ACINETOBACTER INFECTION; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL INFECTION; CANDIDA; CANDIDIASIS; CATHETER ASSOCIATED URINARY TRACT INFECTION; CATHETER INFECTION; CENTRAL VENOUS CATHETER ASSOCIATED BLOOD STREAM INFECTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; COAGULASE POSITIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DRUG CHOICE; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; HOSPITAL INFECTION; HUMAN; INFECTION RATE; INTENSIVE CARE UNIT; INVASIVE DEVICE ASSOCIATED HOSPITAL INFECTION; KLEBSIELLA; MAJOR CLINICAL STUDY; PATHOGENESIS; PSEUDOMONAS; TURKEY (REPUBLIC); UNIVERSITY HOSPITAL; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 84872821574     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: 10.3906/sag-1203-25     Document Type: Article

References (16)

1. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of healthcare-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309-32.
2. Dizbay M, Bas S, Gursoy A, Simşek H, Maral I, Aktas F. Invasive device-related infection surveillance in intensive care units of Gazi University Hospital in 2006-2007. Turkiye Klinikleri Journal of Medical Sciences 2009; 29: 140-5.
3. Candevir A, Kurtaran B, Kibar F, Karakoc E, Aksu HSZ, Taşova Y. Invasive device-associated nosocomial infections of a teaching hospital in Turkey; four years' experience. Turk J Med Sci 2011; 41: 137-147.
4. Cuellar LE, Fernandez-Maldonado E, Rosenthal VD, Castaneda-Sabogal A, Rosales R, Mayorga-Espichan MJ et al. Device-associated infections rates and mortality in intensive care units of Peruvian Hospitals. International Nosocomial Infection Control Consortium (INICC) findings. Pan American Journal of Public Health 2008; 24: 16-24.
5. Moreno CA, Rosenthal VD, Olarte N, Gomez WV, Sussmann O, Agudelo JG et al. Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals: findings of the International Nosocomial Infection Control Consortium. Infection Control and Hospital Epidemiology 2006; 27: 349-56.
6. Leblebicioǧlu H, Rosenthal VD, Ari{dotless}kan OA, Ozgultekin A, Yalcin AN, Koksal I et al. Device-associated hospital-acquired infection rates in Turkish intensive care units. Findings of the International Nosocomial Infection Control Consortium (INICC). J Hosp Infect 2007; 65: 251-7.
7. Jain R, Danziger LH. Multidrug-resistant acinetobacter infections: an emerging challenge to clinicians. Ann Pharmacother 2004; 38: 1449-59.
8. Raad H, Fang X, Keutgen MX, Jiang Y, Sherertz R, Hachem R. The role of chelators in preventing biofilm formation and catheter-related bloodstream infections. Curr Opin Infect Dis 2008; 21: 385-92.
9. Mermel LA, Farr BM, Sheretz RJ, Raad II, O'Grady N, Harris JS et al. Guidelines for the management of intravascular catheterrelated infections. Clin Infect Dis 2001; 32: 1249-72.
10. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG et al. Guidelines for the prevention of intravascular catheter-related infections. MMWR 2002; 51/ RR-10; 1-29.
11. Labelle A, Micek ST, Roubinian N, Kollef M. Treatment-related risk factors for hospital mortality in Candida bloodstream infections. Crit Care Med 2008; 36: 2967-72.
12. Graves N, Tong E, Morton A, Halton K, Curtis M, Lairson D et al. Factors associated with health care-acquired urinary tract infection. Am J Infect Control 2007; 35: 387-92.
13. Laupland K, Bagshaw S, Kirkpatrick AW, Ross T, Church DL. Intensive care unit-acquired urinary tract infections in a regional critical care system. Crit Care Med 2005; 9: 60-5.
14. Stefani S, Varaldo PE. Epidemiology of methicillin resistant staphylococci in Europe. Clin Microbiol Inf 2003; 9: 1179-86.
15. Saba R, İnan D, Turhan O, Yalci{dotless}n AN, Gunseren F, Mami{dotless}koǧlu L. Surveillance of antimicrobial use in a Turkish university hospital. Turk J Med Sci 2011; 41: 701-710.
16. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobialresistant Staphylococcus aureus, Enterococcus, Gram-negative bacilli, Clostridium difficile and Candida. Ann Intern Med 2002; 136: 834-4.